- Home
- NICE vs QGEN Comparison
NICE vs QGEN Comparison
Compare NICE & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NICE
- QGEN
- Stock Information
- Founded
- NICE 1986
- QGEN 1986
- Country
- NICE Israel
- QGEN Netherlands
- Employees
- NICE N/A
- QGEN N/A
- Industry
- NICE Computer Software: Prepackaged Software
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NICE Technology
- QGEN Health Care
- Exchange
- NICE Nasdaq
- QGEN Nasdaq
- Market Cap
- NICE 11.1B
- QGEN 9.1B
- IPO Year
- NICE 1996
- QGEN 1996
- Fundamental
- Price
- NICE $162.61
- QGEN $46.76
- Analyst Decision
- NICE Buy
- QGEN Buy
- Analyst Count
- NICE 12
- QGEN 7
- Target Price
- NICE $209.75
- QGEN $49.51
- AVG Volume (30 Days)
- NICE 437.5K
- QGEN 1.4M
- Earning Date
- NICE 08-14-2025
- QGEN 07-30-2025
- Dividend Yield
- NICE N/A
- QGEN 2.83%
- EPS Growth
- NICE 28.89
- QGEN N/A
- EPS
- NICE 7.17
- QGEN 0.42
- Revenue
- NICE $2,776,155,000.00
- QGEN $2,002,874,000.00
- Revenue This Year
- NICE $8.98
- QGEN $6.36
- Revenue Next Year
- NICE $6.91
- QGEN $6.18
- P/E Ratio
- NICE $22.76
- QGEN $110.70
- Revenue Growth
- NICE 12.63
- QGEN 3.31
- 52 Week Low
- NICE $137.19
- QGEN $37.63
- 52 Week High
- NICE $200.65
- QGEN $47.93
- Technical
- Relative Strength Index (RSI)
- NICE 43.48
- QGEN 64.44
- Support Level
- NICE $164.29
- QGEN $46.25
- Resistance Level
- NICE $171.77
- QGEN $47.70
- Average True Range (ATR)
- NICE 4.20
- QGEN 0.62
- MACD
- NICE -1.60
- QGEN -0.00
- Stochastic Oscillator
- NICE 2.86
- QGEN 68.56
About NICE NICE Ltd
NICE Ltd is an enterprise software company that serves the customer engagement and financial crime and compliance markets. Software is deployed primarily on the cloud, but also on premises. Within customer engagement, Nice's CXone is the leading CCaaS platform providing solutions such as call routing, interactive voice response, digital self-service, and workforce engagement management. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money-laundering, and compliance solutions.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).